Anti-tumor activity of betulinic acid and its apoptotic on kb cell lines

• In: SIG Bioavailability / Bioequivalence - Poster Session
• At: Salvadore (Brazil) (2006)
• Type: Poster
• Poster code: BB-P-003
• By: MA, Li (Beijing Institute of Biomedicine, China)
• Co-author(s): Wu, Hongyu (Beijing Institute of Biomedicine, China)
  Ni, Mingyu (Beijing Institute of Biomedicine, China)
  Wang, Jiaping (Beijing Institute of Biomedicine, China)
  
• Abstract:

  This paper focused on the study of the in vitro anticancer activity of Betulinic Acid (BetA) and growth inhibition of S180 in vivo.
  
  BetA 800,1 200 mg•kg-1 i.g. markedly inhibited the growth of S180 cell in vivo. By the way of our lab, MTT assay showed that BetA could inhibit the proliferation, in a dosage dependent manner, of the cells of..

The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login